Lakefront Biotherapeutics | GLPG - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
argenx SE USD 1000K 172K 2026-03
AstraZeneca USD 484M 181M 2025-12
Biogen USD 72.6M 12.6M 2025-06
Genmab DKK 10M 27M 2025-12
Gilead Sciences USD 240M 15M 2026-03
GlaxoSmithKline GBP 167M 21M 2026-03
GRIFOLS EUR 141.43M 61.28M 2025-06
Hikma Pharmaceutical USD 67M 47M 2025-12
Incyte USD 569K 13K 2026-03
Merck EUR 104M 17M 2026-03
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 343M 39M 2026-03
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 178M 203M 2026-03
UCB EUR 49M 29M 2025-12
Vertex Pharmaceuticals USD 3.3M 0 2025-12